RxDoctor Payments Data

Isaac Ogunseyitan

Psychiatric/Mental Health · Fort Worth, TXNPI 1851872816

Payments from drug & device makers

$4,759in general payments, 2019–2025

Across 251 payments — averaging $18.96 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Neurocrine Biosciences, Inc.$1K
  • Teva Pharmaceuticals USA, Inc.$676
  • Johnson & Johnson$347
  • Alkermes, Inc.$339
  • Lundbeck LLC$317
  • AbbVie$296
  • plus $1K from 7 others

What the payments were for

  • Food & beverage$4,53895%
  • Education$2215%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$4,759 in reported general payments places this provider in the 90th percentile of 2,724 psychiatric/mental health providers in Texas.

See all psychiatric/mental health providers in Texas

Medicare billing

Part B allowed, 2024
$1,873
Medicare patients
13
Services billed
22

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Invega SustennaPaliperidone Palmitate16$49,069
Abilify MaintenaAripiprazole15$45,174
Lurasidone Hcl12$1,506
Trazodone Hcl97$1,186
Divalproex Sodium ErDivalproex Sodium24$1,010
Aripiprazole23$821
Mirtazapine63$771
Quetiapine Fumarate53$728
Venlafaxine Hcl ErVenlafaxine Hcl35$584
Hydroxyzine Pamoate41$575
Buspirone Hcl24$411
Escitalopram Oxalate23$296
Bupropion Hcl SrBupropion Hcl23$289
Gabapentin24$272
Fluoxetine Hcl26$253

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Johnson & JohnsonInvega Sustenna$347$49,06916 claims
Otsuka America Pharmaceutical, Inc.Abilify Maintena$255$45,17415 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 2,724 psychiatric/mental health providers in Texas.

Other psychiatric/mental health in Fort Worth

See the full list for Texas

Where these figures come from

Is this you, or does something look wrong? →